ET
UTHR icon

Entropy Technologies’s United Therapeutics UTHR Stock Holding History

Entropy Technologies’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,940
Closed -$945K – 1176
2025
Q4 		$945K Buy
1,940
+740
+62% +$345K 0.05% 403
2025
Q3 		$503K Buy
+1,200
New +$404K 0.04% 516
2024
Q4 		– Sell
-1,683
Closed -$603K – 1011
2024
Q3 		$603K Sell
1,683
-1,297
-44% -$438K 0.06% 388
2024
Q2 		$949K Buy
+2,980
New +$789K 0.1% 250

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Entropy Technologies's UTHR Position: Q1 2026 in Review

Entropy Technologies sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 1,940 shares — an estimated $945K sold.

Entropy Technologies first reported a position in UTHR in Q2 2024 and held it in 4 quarters. The position peaked at $949K in Q2 2024. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Entropy Technologies reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Entropy Technologies sold 1,940 United Therapeutics shares in Q1 2026, an estimated $945K.
  • Entropy Technologies first reported a position in United Therapeutics in Q2 2024 and held it in 4 quarters.
  • Entropy Technologies's United Therapeutics position peaked at $949K in Q2 2024.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Entropy Technologies's 13F filing for Q1 2026, filed 14 May 2026.